Is the outlook grey for WR-2721 as a clinical radioprotector?

Denekamp, J

Is the outlook grey for WR-2721 as a clinical radioprotector? [electronic resource] - International journal of radiation oncology, biology, physics Aug 1983 - 1247-9 p. digital

Publication Type: Letter

0360-3016

10.1016/0360-3016(83)90194-3 doi


Amifostine--therapeutic use
Animals
Humans
Neoplasms--radiotherapy
Organothiophosphorus Compounds--therapeutic use
Radiation-Protective Agents--therapeutic use